Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
BPC-157's first controlled human trial (NCT07437547) only began in 2026, with results expected around 2027
Some peptides may not mix well with certain immune drugs, steroids, or anticoagulants
For example: Around a strained Achilles tendon Near a rotator cuff injury SubQ in the abdomen for systemic inflammation Localized delivery may enhance growth factor expression and collagen synthesis directly at the site of damage
So a 0.25 mg dose = 0.25 ml = 25 units on a U-100 insulin syringe
Example: A patient presents with shoulder pain and receives an E/M service along with a Toradol injection
Again this is rare and likely has more to do with preservative and other things in the injection other than cobalmin since our bodies need this molecule to survive
